282 related articles for article (PubMed ID: 10028017)
21. Circumvention of the induction of resistance in murine experimental autoimmune thyroiditis by recombinant IL-1 beta.
Nabozny GH; Kong YC
J Immunol; 1992 Aug; 149(3):1086-92. PubMed ID: 1634763
[TBL] [Abstract][Full Text] [Related]
22. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice.
Balasa B; Krahl T; Patstone G; Lee J; Tisch R; McDevitt HO; Sarvetnick N
J Immunol; 1997 Nov; 159(9):4620-7. PubMed ID: 9379064
[TBL] [Abstract][Full Text] [Related]
23. Prevention and reversal of experimental autoimmune thyroiditis (EAT) in mice by administration of anti-L3T4 monoclonal antibody at different stages of disease development.
Stull SJ; Kyriakos M; Sharp GC; Braley-Mullen H
Cell Immunol; 1988 Nov; 117(1):188-98. PubMed ID: 2902931
[TBL] [Abstract][Full Text] [Related]
24. The effects of a monoclonal antibody to interferon-gamma on experimental autoimmune thyroiditis (EAT): prevention of disease and decrease of EAT-specific T cells.
Tang H; Mignon-Godefroy K; Meroni PL; Garotta G; Charreire J; Nicoletti F
Eur J Immunol; 1993 Jan; 23(1):275-8. PubMed ID: 8419180
[TBL] [Abstract][Full Text] [Related]
25. Induction of experimental autoimmune thyroiditis in IL-12-/- mice.
Chen K; Wei Y; Sharp GC; Braley-Mullen H
J Immunol; 2001 Aug; 167(3):1720-7. PubMed ID: 11466396
[TBL] [Abstract][Full Text] [Related]
26. CD40-mediated stimulation contributes to lymphocyte proliferation, antibody production, eosinophilia, and mastocytosis during an in vivo type 2 response, but is not required for T cell IL-4 production.
Lu P; Urban JF; Zhou XD; Chen SJ; Madden K; Moorman M; Nguyen H; Morris SC; Finkelman FD; Gause WC
J Immunol; 1996 May; 156(9):3327-33. PubMed ID: 8617957
[TBL] [Abstract][Full Text] [Related]
27. IL-12 up-regulates CD40 ligand (CD154) expression on human T cells.
Peng X; Remacle JE; Kasran A; Huylebroeck D; Ceuppens JL
J Immunol; 1998 Feb; 160(3):1166-72. PubMed ID: 9570530
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor-beta has contrasting effects in the presence or absence of exogenous interleukin-12 on the in vitro activation of cells that transfer experimental autoimmune thyroiditis.
Fondal W; Sampson C; Sharp GC; Braley-Mullen H
J Interferon Cytokine Res; 2001 Nov; 21(11):971-80. PubMed ID: 11747629
[TBL] [Abstract][Full Text] [Related]
29. Blockade of CD40-CD40 ligand pathway induces tolerance in murine contact hypersensitivity.
Tang A; Judge TA; Turka LA
Eur J Immunol; 1997 Dec; 27(12):3143-50. PubMed ID: 9464799
[TBL] [Abstract][Full Text] [Related]
30. Evidence for a continued requirement for CD40/CD40 ligand (CD154) interactions in the progression of LP-BM5 retrovirus-induced murine AIDS.
Green KA; Noelle RJ; Green WR
Virology; 1998 Feb; 241(2):260-8. PubMed ID: 9499800
[TBL] [Abstract][Full Text] [Related]
31. Interference with CD4+CD25+ T-cell-mediated tolerance to experimental autoimmune thyroiditis by glucocorticoid-induced tumor necrosis factor receptor monoclonal antibody.
Morris GP; Kong YC
J Autoimmun; 2006 Feb; 26(1):24-31. PubMed ID: 16253477
[TBL] [Abstract][Full Text] [Related]
32. CD40 ligand is expressed and functional on activated neonatal T cells.
Splawski JB; Nishioka J; Nishioka Y; Lipsky PE
J Immunol; 1996 Jan; 156(1):119-27. PubMed ID: 8598451
[TBL] [Abstract][Full Text] [Related]
33. CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice.
Wiley JA; Harmsen AG
J Immunol; 1995 Oct; 155(7):3525-9. PubMed ID: 7561048
[TBL] [Abstract][Full Text] [Related]
34. Anti-CD40L accelerates renal disease and adenopathy in MRL-lpr mice in parallel with decreased thymocyte apoptosis.
Russell JQ; Mooney T; Cohen PL; MacPherson B; Noelle RJ; Budd RC
J Immunol; 1998 Jul; 161(2):729-39. PubMed ID: 9670949
[TBL] [Abstract][Full Text] [Related]
35. Immunization with thyroglobulin-specific cytotoxic T cell hybridoma induces anti-thyroglobulin antibodies: characteristics of monoclonal anti-thyroglobulin auto-antibody.
Bedin C; Mignon-Godefroy K; Brazillet MP; Tang H; Charreire J
Cell Immunol; 1993 Feb; 146(2):227-37. PubMed ID: 7513615
[TBL] [Abstract][Full Text] [Related]
36. Reduction of atherosclerosis in mice by inhibition of CD40 signalling.
Mach F; Schönbeck U; Sukhova GK; Atkinson E; Libby P
Nature; 1998 Jul; 394(6689):200-3. PubMed ID: 9671306
[TBL] [Abstract][Full Text] [Related]
37. CD40 ligand expressed on B cells in the BXSB mouse model of systemic lupus erythematosus.
Blossom S; Chu EB; Weigle WO; Gilbert KM
J Immunol; 1997 Nov; 159(9):4580-6. PubMed ID: 9379059
[TBL] [Abstract][Full Text] [Related]
38. Immunostimulatory probiotic Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 do not induce pathological inflammation in mouse model of experimental autoimmune thyroiditis.
Zhou JS; Gill HS
Int J Food Microbiol; 2005 Aug; 103(1):97-104. PubMed ID: 16084270
[TBL] [Abstract][Full Text] [Related]
39. Identification of a thyroiditogenic sequence within the thyroglobulin molecule.
Chronopoulou E; Carayanniotis G
J Immunol; 1992 Aug; 149(3):1039-44. PubMed ID: 1378862
[TBL] [Abstract][Full Text] [Related]
40. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response.
Early GS; Zhao W; Burns CM
J Immunol; 1996 Oct; 157(7):3159-64. PubMed ID: 8816428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
